시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 탈모 치료 시장 보고서(2025년)
Alopecia Treatment Global Market Report 2025
상품코드 : 1760454
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

탈모 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 예측 기간 동안의 성장은 비침습적 치료법 채택 증가, 개인 맞춤형 의학에 대한 수요 증가, 정신 건강과 자존감에 대한 관심 증가, 탈모 원인 및 치료법에 대한 소비자 인식 향상, 탈모 치료제 임상시험의 증가에 기인할 수 있습니다. 예측 기간에 있어서의 주요 동향으로서는 줄기 세포를 이용한 모발 재생의 발전, 다혈소판 혈장(다혈소판 혈장) 요법의 이용, 자가면역 관련 탈모증에 대한 JAK 억제제의 개발, 레이저 모발 치료의 혁신, 발모를 촉진하는 장착형 디바이스의 등장 등이 있습니다.

탈모의 유병률 증가는 탈모 치료 시장의 성장을 가속시킬 것으로 예측됩니다. 스트레스 수준 상승과 같은 요인으로 인해 탈모의 유병률이 증가하고 있으며, 이는 정상적인 모발 성장 주기를 방해하고 텔로겐 유출과 같은 질환을 유발하여 과도한 탈모를 유발할 수 있습니다. 나라를 거점으로 하는 피부과 전문의 의사회인 미국 피부과학회는 남성 5,000만명, 여성 3,000만명을 포함한 8,000만명의 미국인이 탈모의 영향을 받고 있다고 보고했습니다.

탈모 치료 시장의 주요 기업은 경구 저분자 야누스 키나아제(JAK) 억제제와 같은 혁신적인 솔루션의 개발에 주력하고 있으며, 치료 효과 개선, 발모 촉진, 중증 또는 저항성 원형 탈모증 환자에 대한 표적 치료의 제공을 목표로 하고 있습니다. 이 약은 하나 이상의 야누스 키나아제 효소(JAK1, JAK2, JAK3, TYK2)의 활성을 억제하도록 설계된 표적 의약품의 일종입니다. 2024년 7월 인도에 본사를 둔 제약 회사인 Sun Pharmaceutical Industries Limited는 성인의 중증 원형 탈모증의 치료로서 LEQSELVI에 대한 미국 식품의약국(FDA)으로부터 승인을 취득했습니다. 권장 복용량은 1회 8mg을 하루 2회, 식사의 유무에 관계없이 경구 투여합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

SHW
영문 목차

영문목차

Alopecia treatment encompasses a range of medical and cosmetic methods aimed at managing and reducing hair loss, and in some cases, encouraging hair regrowth. Treatment options include topical solutions including minoxidil, oral medications, steroid injections, and therapies targeting the immune system. The choice of treatment depends on the type and severity of alopecia.

The primary treatment forms in the alopecia market include drug therapy, hair transplant services, and low-level laser therapy. Drug therapies include both prescription and over-the-counter pharmaceutical treatments that address hair loss through various mechanisms. These treatments can be administered through different routes, such as topical applications and injections, and are used for conditions including alopecia areata, alopecia totalis, alopecia universalis, alopecia barbae, chemotherapy-induced alopecia, and others. The treatments are available for both males and females. Key end users of these treatments include hospitals, physician offices, dermatology clinics, and other healthcare facilities.

The alopecia treatment market research report is one of a series of new reports from The Business Research Company that provides alopecia treatment market statistics, including alopecia treatment industry global market size, regional shares, competitors with a alopecia treatment market share, detailed alopecia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the alopecia treatment industry. The alopecia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The alopecia treatment market size has grown strongly in recent years. It will grow from $9.56 billion in 2024 to $10.22 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historical period can be attributed to the rising prevalence of alopecia, an aging population, hormonal changes, genetic factors, increased awareness of hair loss treatments, expansion of the cosmetic and dermatology industries, and better access to healthcare.

The alopecia treatment market size is expected to see strong growth in the next few years. It will grow to $13.22 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth during the forecast period can be attributed to the rising adoption of non-invasive treatments, increasing demand for personalized medicine, a growing focus on mental health and self-esteem, greater consumer awareness of hair loss causes and treatments, and a rise in clinical trials for alopecia therapies. Key trends in the forecast period include advancements in stem cell-based hair regeneration, the use of platelet-rich plasma (PRP) therapy, the development of JAK inhibitors for autoimmune-related alopecia, innovations in laser hair therapy, and the emergence of wearable devices for stimulating hair growth.

The growing prevalence of hair loss is expected to accelerate the growth of the alopecia treatment market. Hair loss refers to the condition in which an individual experiences partial or complete hair loss from the scalp or other areas of the body. The prevalence of hair loss is rising due to factors such as elevated stress levels, which can disrupt the normal hair growth cycle and trigger conditions including telogen effluvium, resulting in excessive hair shedding. As more individuals seek effective solutions to manage and reverse hair loss, the demand for advanced and accessible alopecia treatments is increasing. For example, in October 2024, the American Academy of Dermatology, a U.S.-based professional medical association specializing in dermatology, reported that 80 million Americans were affected by hair loss, including 50 million men and 30 million women. Thus, the growing prevalence of hair loss is fueling the expansion of the alopecia treatment market.

Leading companies in the alopecia treatment market are focusing on developing innovative solutions, such as oral small-molecule Janus kinase (JAK) inhibitors, to improve treatment efficacy, accelerate hair regrowth, and provide targeted therapy for patients with severe or resistant forms of alopecia areata. Oral small-molecule JAK inhibitors are a class of targeted pharmaceutical drugs designed to block the activity of one or more Janus kinase enzymes (JAK1, JAK2, JAK3, and TYK2). For example, in July 2024, Sun Pharmaceutical Industries Limited, a pharmaceutical company based in India, received approval from the U.S. Food and Drug Administration (FDA) for LEQSELVI, an oral JAK inhibitor, for the treatment of adults with severe alopecia areata. LEQSELVI selectively inhibits the JAK1 and JAK2 enzymes, which play a key role in the immune system's attack on hair follicles in this autoimmune disorder. The recommended dosage is 8 mg orally twice daily, with or without food. This FDA approval introduces a new, effective treatment option for individuals suffering from alopecia areata, a condition that can have significant physical, emotional, and social effects.

In February 2023, Sun Pharmaceutical Industries Limited, an India-based pharmaceutical company, acquired Concert Pharmaceuticals for $576 million. This acquisition provided Sun Pharma with access to deuruxolitinib, a late-stage oral JAK inhibitor being developed for the treatment of alopecia areata. The move strengthens Sun Pharma's dermatology portfolio and bolsters its position in the global specialty pharmaceuticals market. Concert Pharmaceuticals Inc. is a US-based biopharmaceutical company, specializing in developing novel small-molecule drugs for treating alopecia areata.

Major players in the alopecia treatment market are Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Inc., Incyte Corporation, Hims & Hers Health Inc., Bosley Inc., Hair Club Co., Dermavant Sciences Inc., Histogen Inc., Capillus llc, Aclaris Therapeutics Inc., Nutrafol, Alvi Armani Co, Rogaine, Theradome Inc., Viviscal Ltd, Arena Pharmaceuticals Ltd, Cassiopea SA, Follica Inc., RepliCel Life Sciences Inc., HairClone Ltd, Revian Inc., and Nioxin.

North America was the largest region in the alopecia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in alopecia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the alopecia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The alopecia treatment market consists of revenues earned by entities providing a wide range of services, such as medical consultations, hair restoration procedures, topical and oral medications, laser therapies, and personalized treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The alopecia treatment market also includes sales of products such as topical solutions, oral medications, hair growth shampoos, and laser therapy devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Alopecia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on alopecia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for alopecia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The alopecia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Alopecia Treatment Market Characteristics

3. Alopecia Treatment Market Trends And Strategies

4. Alopecia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Alopecia Treatment Growth Analysis And Strategic Analysis Framework

6. Alopecia Treatment Market Segmentation

7. Alopecia Treatment Market Regional And Country Analysis

8. Asia-Pacific Alopecia Treatment Market

9. China Alopecia Treatment Market

10. India Alopecia Treatment Market

11. Japan Alopecia Treatment Market

12. Australia Alopecia Treatment Market

13. Indonesia Alopecia Treatment Market

14. South Korea Alopecia Treatment Market

15. Western Europe Alopecia Treatment Market

16. UK Alopecia Treatment Market

17. Germany Alopecia Treatment Market

18. France Alopecia Treatment Market

19. Italy Alopecia Treatment Market

20. Spain Alopecia Treatment Market

21. Eastern Europe Alopecia Treatment Market

22. Russia Alopecia Treatment Market

23. North America Alopecia Treatment Market

24. USA Alopecia Treatment Market

25. Canada Alopecia Treatment Market

26. South America Alopecia Treatment Market

27. Brazil Alopecia Treatment Market

28. Middle East Alopecia Treatment Market

29. Africa Alopecia Treatment Market

30. Alopecia Treatment Market Competitive Landscape And Company Profiles

31. Alopecia Treatment Market Other Major And Innovative Companies

32. Global Alopecia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Alopecia Treatment Market

34. Recent Developments In The Alopecia Treatment Market

35. Alopecia Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기